Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2017
Multiparameter Intracellular Cytokine Staining
Patricia Lovelace, Holden T Maecker
Methods in Molecular Biology (Clifton, N.J.)
|
December 1, 2010
Multiparameter intracellular cytokine staining
Patricia Lovelace, Holden T Maecker
Nature Immunology
|
December 9, 2003
Two isoforms of otubain 1 regulate T cell anergy via GRAIL
Luis Soares, Christine Seroogy, Heidi Skrenta, et al.
Cell Systems
|
October 18, 2016
Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans
Shai S Shen-Orr, David Furman, Brian A Kidd, et al.
Science Translational Medicine
|
March 17, 2017
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Sharareh Gholamin, Siddhartha S Mitra, Abdullah H Feroze, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2012
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2017
Multiparameter Intracellular Cytokine Staining
Patricia Lovelace, Holden T Maecker
Methods in Molecular Biology (Clifton, N.J.)
|
December 1, 2010
Multiparameter intracellular cytokine staining
Patricia Lovelace, Holden T Maecker
Nature Immunology
|
December 9, 2003
Two isoforms of otubain 1 regulate T cell anergy via GRAIL
Luis Soares, Christine Seroogy, Heidi Skrenta, et al.
Cell Systems
|
October 18, 2016
Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans
Shai S Shen-Orr, David Furman, Brian A Kidd, et al.
Science Translational Medicine
|
March 17, 2017
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Sharareh Gholamin, Siddhartha S Mitra, Abdullah H Feroze, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2012
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.
Page
of 1